ABSTRACT
Diabetic autonomic neuropathy can cause heart disease, gastrointestinal symptoms, genitourinary disorders, and metabolic disease. Strict glycemic control can slow the onset of diabetic autonomic neuropathy and sometimes reverse it. Pharmacologic and nonpharmacologic therapies are available to treat symptoms.
Footnotes
↵* This author has indicated that he has received grant or research support from multiple pharmaceutical corporations and serves as a consultant on the speakers bureaus of multiple pharmaceutical corporations.
- Copyright © 2001 The Cleveland Clinic Foundation. All Rights Reserved.
Registration is Now Required for Free Access to CCJM Content
Register once and log in for full access to articles and content. Click “Register” in the upper right corner and follow the simple instructions to create a new account.
If you are using a mobile device, click on the settings icon to access the Register link.
Jump to section
Related Articles
Cited By...
- Effects of a Single Bout of Interval Hypoxia on Cardiorespiratory Control and Blood Glucose in Patients With Type 2 Diabetes
- Acute augmentation of epoxygenated fatty acid levels rapidly reduces pain-related behavior in a rat model of type I diabetes
- New insights in diabetic autonomic neuropathy in children and adolescents
- Eighteen Years of Fair Glycemic Control Preserves Cardiac Autonomic Function in Type 1 Diabetes
- The Association Between Cardiovascular Autonomic Neuropathy and Mortality in Individuals With Diabetes: A meta-analysis
- Diabetic Autonomic Neuropathy